AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 282: R1297-R1307, 2002. First published January 17, 2002; doi:10.1152/ajpregu.00584.2001
0363-6119/02 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/5/R1297    most recent
00584.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (42)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kean, L.
Right arrow Articles by Dow, J. A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kean, L.
Right arrow Articles by Dow, J. A. T.
Vol. 282, Issue 5, R1297-R1307, May 2002

Two nitridergic peptides are encoded by the gene capability in Drosophila melanogaster

Laura Kean1, William Cazenave2, Laurence Costes2, Kate E. Broderick1, Shirley Graham1, Valerie P. Pollock1, Shireen A. Davies1, Jan A. Veenstra2, and Julian A. T. Dow1

1 Division of Molecular Genetics, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G11 6NU, United Kingdom; and 2 Laboratoire de Neuroendocrinologie des Insectes, Université Bordeaux I, 33405 Talence Cedex, France


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

A Drosophila gene (capability, capa) at 99D on chromosome 3R potentially encodes three neuropeptides: GANMGLYAFPRV-amide (capa-1), ASGLVAFPRV-amide (capa-2), and TGPSASSGLWGPRL-amide (capa-3). Capa-1 and capa-2 are related to the lepidopteran hormone cardioacceleratory peptide 2b, while capa-3 is a novel member of the pheromone biosynthesis-activating neuropeptide/diapause hormone/pyrokinin family. By immunocytochemistry, we identified four pairs of neuroendocrine cells likely to release the capa peptides into the hemolymph: one pair in the subesophageal ganglion and the other three in the abdominal neuromeres. In the Malpighian (renal) tubule, capa-1 and capa-2 increase fluid secretion rates, stimulate nitric oxide production, and elevate intracellular Ca2+ and cGMP in principal cells. Capa-stimulated fluid secretion, but not intracellular Ca2+ concentration rise, is inhibited by the guanylate cyclase inhibitor methylene blue. The actions of capa-1 and capa-2 are not synergistic, implying that both act on the same pathways in tubules. The capa gene is thus the first to be shown to encode neuropeptides that act on renal fluid production through nitric oxide.

neuropeptide; Malpighian tubule; trp; nitric oxide


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

THE NEUROPEPTIDE cardioacceleratory peptide (CAP) 2b (CAP2b) has a unique mode of action, involving the generation and autocrine action of nitric oxide (NO). It is one of a number of cardioactive peptides (CAP1a, CAP1b, CAP2a, CAP2b, and CAP2c) found in the hawk moth Manduca sexta (35, 36). Manduca CAPs have been shown not only to affect heart rate in insects and Crustacea (31) but also to modulate hindgut contractions in insects (34). Sequence is not yet available for CAP1a, CAP1b, or CAP2c, although CAP2a (PFCNAFTGC) has been shown to be identical to crustacean CAP (1). Purification and sequencing of CAP2b from ventral cords of adult pharate moths showed that this peptide exists as an octapeptide, pyro-ELYAFPRV-amide (11). A peptide with physicochemical properties very similar to CAP2b has been demonstrated in Drosophila and was shown to have potent action on epithelial fluid transport by Malpighian (renal) tubules (3). None of the other M. sexta CAPs modulates fluid transport by Drosophila tubules (3).

In tubules, CAP2b stimulation of fluid transport is triggered by activation of the NO-cGMP signaling pathway. CAP2b treatment results in increased intracellular cGMP concentration (3), and application of cGMP or CAP2b to intact tubules results in an increase in transepithelial potential (3, 20), implying activation of the apical vacuolar ATPase in tubule principal cells (6). Furthermore, the soluble guanylate cyclase inhibitor methylene blue inhibits CAP2b-stimulated transport and abolishes the rise in cGMP, suggesting that synthesis of cGMP is important in CAP2b action. Soluble guanylate cyclase is the major intracellular target of NO, which is synthesized by NO synthase (NOS) (2).

Drosophila tubules express the single-copy gene for Drosophila NOS (dNOS) (4), encoding a Ca2+/calmodulin-sensitive NOS that has most similarity to vertebrate neuronal NOS (27). We previously showed that NOS activity increases on CAP2b stimulation (4). More recently, NOS has been immunolocalized to only principal cells (2), suggesting compartmentalization of the NO signaling pathway in tubules.

Thus CAP2b is a particularly intriguing insect neuropeptide: the first such peptide to be defined as an extracellular modulator of NO signaling in insects and one that also stimulates Ca2+ signaling via Ca2+ entry. The Drosophila genome project is now essentially complete, and sequence for the 130 MB of euchromatic DNA is publicly available. This allows the genetic correlates of physiological properties to be established unambiguously. We show here that the Drosophila genome contains a neuropeptide gene, capability (capa), which encodes two CAP2b-related peptides (capa-1 and capa-2), together with a third (capa-3), which is most closely related to Bombyx diapause hormone. Similar to lepidopteran CAP2b, the authentic Drosophila peptides capa-1 and capa-2 act on the Malpighian tubule to stimulate fluid production through intracellular Ca2+, NO, and cGMP.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Drosophila stocks. Drosophila were maintained on a 12:12-h light-dark cycle on standard corn meal-yeast-agar medium at 25°C. The Oregon R strain (8) and the P{GAL4} (30) and upstream activating sequence G (UASG)-aequorin lines (28) have been described previously. To produce flies in which apoaequorin was expressed in a particular spatial or temporal pattern, the appropriate GAL4 driver line was crossed with a line carrying the apoaequorin transgene under control of the yeast UASG promoter, as previously described (28). In the resultant progeny, apoaequorin is expressed only in cells in which GAL4 is being expressed. For these experiments, the c42 and c710 lines were used to drive expression to the principal and stellate cells of the main segment, respectively (28, 33); such "c42-aeq" and "c710-aeq" flies were maintained as homozygous lines. For tubule dissections, flies were cooled on ice and then decapitated before isolation of whole tubules.

Materials. Coelenterazine was purchased from Molecular Probes and dissolved in ethanol before use. Anti-cGMP antibody and fluorescein-conjugated secondary antibody were purchased from Calbiochem, cGMP RIA kits (Amerlex-M) from Amersham Pharmacia, Schneider's medium and Ca2+-free Schneider's medium from GIBCO Life Technologies, and zaprinast, the cGMP-dependent phosphodiesterase inhibitor, from Calbiochem. The neuropeptides pyro-ELYAFPRV-amide (CAP2b) (3), GANMGLYAFPRV-amide (capa-1), and ASGLVAFPRV-amide (capa-2) and the precursor peptide SDPSLANSLRDGLEAGVLDG were synthesized by Research Genetics. All other chemicals were obtained from Sigma.

Identification of capability. The CAP2b peptide is COOH-terminally amidated and is presumably flanked by cleavage sites in the prepropeptide but is too short for straightforward similarity searching. Accordingly, the "bait" peptide ELYAFPRVGKRELYAFPRVGKR was used to search the available Drosophila genomic and cDNA sequence at the Berkeley Drosophila Genome project site (www.fruitfly.org) using the TBLASTN search at lowest stringency. In early 2000, this produced hits against a single expressed sequence tag (clone GH21009) and to the extreme 3' end of a previously published genomic sequence for the transient receptor potential (trp) gene at 99D. The clone was obtained and sequenced fully on both strands. The deduced peptide was compared with known proteins using the National Center for Biotechnology Information BLASTP similarity search, again at low stringency, and was found to contain two peptides that resembled CAP2b, together with a peptide that resembled Bombyx mori diapause hormone. All sequences were flanked with monobasic or dibasic cleavage sites (37).

The searches were continued until submission of the manuscript in June 2001, without detection of any further matches. Inasmuch as the euchromatic genome of D. melanogaster is known to high accuracy, the probability that there is any further gene encoding peptides closely similar to CAP2b is very low.

Generation of antisera to capa-encoded peptides. Antisera were raised to two different peptides: ASGLVAFPRV-amide (capa-2) and SDPSLANSLRDGLEAGVLDG, part of the capa gene product encoded by the second exon. Conjugates were prepared by coupling 2 mg of each peptide to 5 mg of thyroglobulin, with difluorodinitrobenzene used as the coupling reagent, as described elsewhere (32). A single female New Zealand White rabbit was injected with each conjugate. The first injections were performed with complete Freund's adjuvant; for subsequent injections, incomplete Freund's adjuvant was used. The rabbit injected with the capa-2 conjugate was injected every 6 wk for a total of four injections. The rabbit injected with the capa-precursor peptide was injected every 2-4 wk for a total of four injections. Rabbits were bled, and serum was collected 10 days after each booster injection.

The antiserum to capa precursor peptide gave some background immunoreactivity and, therefore, was purified on a capa precursor HiTrap (Amersham Pharmacia Biotech) affinity column according to the manufacturer's instructions. Both acid- and base-sensitive affinity-purified antibodies gave good immunostaining, but the acid-sensitive antibodies were used here. IgG against capa-2 and the precursor peptide were purified from the respective antisera with octanoic acid, dialyzed against HPLC-grade water, and lyophilized. Aliquots were then labeled with 6-((7-amino-4-methylcoumarin-3-acetyl)amino) hexanoic acid succinimidyl ester (AMCA) and/or 5-(and-6)-carboxytetramethylrhodamine succinimidyl ester (tetrarhodamine) (Molecular Probes), as described elsewhere (38a).

Transport (fluid secretion) assays. Malpighian tubules were isolated into 10-µl drops of a 1:1 mixture of Schneider's medium and Drosophila saline (in mmol/l: 117.5 NaCl, 20 KCl, 2 CaCl2, 8.5 MgCl2, 10.2 NaHCO3, 4.3 NaH2PO4, 15 HEPES, and 20 glucose) under liquid paraffin, and fluid secretion rates were measured as described in detail elsewhere (8) under the conditions described. All peptides were added as solutions in assay medium. Methylene blue, when used, was added as solution in assay medium.

Measurements of intracellular Ca2+ concentration using aequorin transgene. For each assay, 20 tubules from 4- to 14-day-old c42-aeq adults were dissected in Schneider's medium. Tubules were pooled in 160 µl of the same buffer containing the apoaequorin cofactor coelenterazine (2.5 µM final concentration); reconstitution of aequorin occurred on incubation in the dark for 4-6 h (28, 33). Bioluminescence recordings were made using a luminometer (model LB9507, Berthold Wallac); recordings were made every 0.1 s for each tube. Each tube, containing 20 tubules, was used for a single data point; after intracellular Ca2+ concentration ([Ca2+]i) was recorded, tissues were disrupted in 350 µl of lysis solution [1% (vol/vol) Triton X-100 and 100 mM CaCl2], causing complete discharge of the remaining aequorin and allowing estimation of the total amount of aequorin in the sample. Ca2+ concentration was calculated as previously described (28). Mock injections with Schneider's medium were applied to all samples before treatment with neuropeptides.

Determination of NOS activity by the Griess reaction. Fifty intact tubules were dissected into 300 µl of Schneider's medium. Before stimulation with peptide, medium was removed and replaced with fresh Schneider's solution. Capa-1, capa-2, or CAP2b was applied at 10-7 M for 10 min. Samples were chilled on ice and homogenized. The Griess assay was used to detect formation of NO<UP><SUB>2</SUB><SUP>−</SUP></UP>, a stable product of NO, in stimulated and control tubule homogenates. Modified Griess reagent (100 µl; catalog no. G4410, Sigma) and 2.6 ml of water were added to the homogenates, and the reactions were incubated at room temperature in the dark for 20 min. Standard curves were generated using 0-20 µM sodium nitrite (Sigma) standards in Schneider's medium. Absorbance was measured in standards and samples at 540 nm. Concentrations of NO<UP><SUB>2</SUB><SUP>−</SUP></UP> in samples were determined from the standard curve, which was linear over the entire concentration range tested. The Griess assay carried out on tubules did not utilize NADPH and nitrate reductase, inasmuch as initial experiments showed that these reagents did not alter the amount of NO<UP><SUB>2</SUB><SUP>−</SUP></UP> detected in control and stimulated samples (data not shown); this suggests that NO is primarily metabolized to NO<UP><SUB>2</SUB><SUP>−</SUP></UP> in tubules.

Immunocytochemistry. The protocol used for immunohistology was the same as that described elsewhere (38). Antiserum to capa-2 was diluted 1:1,000-1:3,000, and the antiserum to the capa precursor peptide was diluted 1:2,000-1:4,000 or, in the case of affinity-purified antibodies, 1:500. Antiserum to pheromone biosynthesis-activating neuropeptide (PBAN) was a kind gift from Dr. G. Fabrias (16) and was used in a dilution of 1:2,000. Incubations in the primary antibodies were performed overnight. A Texas red-conjugated affinity-purified goat anti-rabbit antibody (Jackson Immunologicals) was used in a dilution of 1:2,000 for visualization of the primary antiserum. For double and triple labelings, the tissues were incubated subsequently with unlabeled peptide antibody, a fluorescein-labeled F(ab) fragment of goat anti-rabbit IgG (Jackson Immunologicals) to visualize the first peptide antibody, and AMCA- and/or tetrarhodamine-labeled purified IgG to visualize one or two of the other peptides.

For immunocytochemical detection of cGMP induced by exposure to capa neuropeptides, intact tubules were preincubated with 10-4 M zaprinast for 10 min and then stimulated with the appropriate peptide at 10-7 M for 10 min. Tubules were fixed in 4% (vol/vol) paraformaldehyde for 30 min, washed twice for 1 h in PBS containing 1% (wt/vol) cold fraction V bovine serum albumin (Sigma)-1% (vol/vol) Triton X-100 (PAT), and incubated overnight in 3% (vol/vol) normal goat serum containing rabbit polyclonal anti-cGMP antibody diluted 1:3,000 in PAT. After three washes in PAT (1 h), tubules were subsequently incubated with fluorescein-labeled secondary antibody (1:250 dilution; Vector Labs) and washed twice for 1 h in PAT and once for 5 min in PBS. All these procedures were carried out at room temperature. Stained tubules were mounted in VectaShield (Vector Labs). Whole mount tubules were examined with a Molecular Dynamics Multiprobe laser scanning confocal upright microscope. The excitation (488 nm) and emission (515 nm) barrier filters were appropriate to the fluorescein-based label of the secondary antibody. Images were viewed with NIH Image.

Measurement of tubule cGMP concentration. cGMP concentrations were measured in isolated tubules by radioimmunoassay using anti-cGMP antibody (Amerlex-M kit, Amersham Pharmacia), as described previously (3). Briefly, 20 tubules per sample were incubated with 10-4 M zaprinast for 10 min in Schneider's medium before stimulation with appropriate neuropeptides for a further 10 min. Samples were quenched with ice-cold ethanol and homogenized. Supernatants were dried and resuspended in 0.05 M sodium acetate buffer (Amersham Pharmacia) and assayed for GMP content.

Statistics. Values are means ± SE. Where appropriate, the significance of difference between data points was analyzed using Student's t-test, with P < 0.05 taken as the critical level.


    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The capa gene. The only hits within the Drosophila genome that gave near-perfect matches for the core CAP2b sequence within the "bait" peptide (using TBLASTN) were expressed sequence tags for clones GH21009, and later GH28004 (GenBank accession no. AI517299). The GH28004 cDNA was obtained from Research Genetics and was sequenced fully on both strands; the resulting cDNA and deduced peptide sequences are shown in Fig. 1A. The gene was named "capability" (capa), because it clearly has the ability to encode two neuropeptides of the CAP2b family. The compact gene contains a 592- and a 71-bp intron (Fig. 1B). Interestingly, the first splice site coincides exactly with the putative signal peptide cleavage site (Fig. 1). There was no evidence from the genomic sequence or the sequenced cDNAs for multiple transcripts from the gene. Capa sits very close to the trp gene (Fig. 1B); only 268 bases separate the end of the published trp cDNA from the start of the capa cDNA. This means that most upstream regulatory sequences for capa could be concentrated in a relatively small area. Within this short upstream region, there is a high density of putative binding sites for Drosophila transcription factors, as assessed by MatInspector (http://transfac.gbf.de/) (26); there are one or more matches for each of deformed, fushi-tarazu, crocodile, broad complex, hunchback, snail, and delta transcription factors. Promoter analysis (http://www.fruitfly.org/seq_tools/promoter.html) reveals a good match, including a TATA box 47 bp upstream of the start of the cDNA sequence. The predicted transcriptional start site is 17 bp upstream of the start of our cDNA sequence. Within the capa cDNA (Fig. 1), there are three potential initiator codons (ATG) in frame with the putative peptides. The first initiator codon (ATG) that is in-frame with the major open reading frame (nt 72-74 of the cDNA; Fig. 1A) is the most likely translational start site, because it produces a prepropeptide with a plausible signal peptide, as is required for secreted proteins (14, 15). The automated annotation of the cDNA sequence by the Berkeley Drosophila Genome Project, however, starts the translation with the initiator codon (ATG) at nucleotides 171-173 of the cDNA (Fig. 1A), but there would be no plausible signal peptide for this initiator site.


View larger version (38K):
[in this window]
[in a new window]
  		Fig. 1.   The capa gene. A: cDNA and deduced peptide sequences of capa. Putative monobasic and dibasic furin cleavage sites are underscored. COOH-terminal amidation signal glycine residues are italicized. Positions of introns in the genomic sequence are marked with ><. The encoded peptide has a signal peptide, with predicted cleavage between amino acid residues STA and ET (encodes by bases 126-140), as predicted by the SignalP program (http: //www.cbs.dtu.dk/services/SignalP/) (18). The predicted capa-1, capa-2, and capa-3 peptides are indicated in blue; the capa precursor peptide used to make an antiserum is indicated in red. The sequence for capa has been deposited in GenBank (accession no. AF203878). *, Stop codon. B: genomic context of capa. Region 99D of chromosome 3R is shown. Neighbors of capa (CG15520) are, on the positive strand, CG15518, a novel gene with no similarities to known genes, and, on the negative strand, trp, a Ca2+ channel implicated in capacitative Ca2+ entry. The large intron in capa is 592 bases long, and the smaller intron is 71 bp; their exact positions are marked in A. The genomic sequence for capa is contained in the Drosophila genomic scaffold (GenBank accession no. AE003771). C: alignment of related peptides. i: Putative members of the CAP2b family, including capa-1 and capa-2, cleavable deduced peptides encoded by the capa gene (this study); CAP2b from Manduca sexta (3); and LYMNAEA_SCPB and LYMNAEA_SCPA, i.e., Lymnaea stagnalis small cardioactive peptides (13, 23). ii: Putative members of the pheromone biosynthesis-activating neuropeptide (PBAN) family and some related peptides, including PBAN_BOMMO from Bombyx mori (39); capa-3, cleavable deduced peptide encoded by the Drosophila melanogaster capa gene (this study); pyrokinins 5 and 6 from the American cockroach Periplaneta americana (24, 25); DH (Bombyx), i.e., Bombyx mori diapause hormone (29); hugin (short), cleavable deduced peptide encoded by the Drosophila hugin gene (GenBank accession no. CAB88005); and ETH1 and ETH2, Drosophila ecdysis-triggering hormones 1 and 2 (ETH1 and ETH2) (22). Residues common to all peptides in a group are shown in bold.

The three putative neuropeptides encoded by capa were named capa-1, capa-2, and capa-3 in order of their position within the prepropeptide. Both CAP2b-like peptides, capa-1 and capa-2, are appropriately flanked with upstream dibasic and downstream monobasic convertase cleavage sites (37), and both have COOH-terminal amidation signals (Fig. 1A). Surprisingly, the same gene also encoded capa-3, a peptide that is closely related to the PBAN and diapause hormone, which at least in Lepidoptera are encoded by the same gene. The deduced peptide capa-3 (Fig. 1, A and C) is flanked by dibasic cleavage sites, has a COOH-terminal amidation signal, and is clearly a member of the FxPRL-amide group, also known as pyrokinins. It is most closely related to the B. mori diapause hormone, sharing the COOH-terminal LWFGPRL-amide with this peptide (Fig. 1C), and pyrokinins 5 and 6 from the American cockroach Periplaneta americana (24, 25). Diapause hormone is responsible for inducing embryonic diapause, which does not occur in Drosophila, and the function of cockroach pyrokinins 5 and 6 is unknown. There is no other significant match to the Helicoverpa PBAN peptide sequence within the Drosophila genome, at the deduced peptide level (searching with BLASTP) or at the nucleotide level (searching with TBLASTN). Nevertheless, capa-3 is probably not the Drosophila PBAN homolog, inasmuch as peptides more closely related to PBAN are potentially encoded by the hugin gene (Fig. 1C). The short neuropeptide of hugin and capa-3 share the pyrokinin signature (FxPRL-amide) with the PBAN family but have no other similarities to PBAN (Fig. 1C). Consequently, the function of capa-3 is far from clear. Although we did not synthesize the predicted capa-3 peptide, we assayed Helicoverpa zea PBAN and leukopyrokinin (a kind gift of Dr. R. Jurenka) and found that neither had an effect on tubules (data not shown). Thus it seems that the role of capa-3 differs from that of the other two peptides encoded by the capa gene.

Localization of the capa peptides by immunocytochemistry. The location of the capa precursor was mapped with three different antisera: one against capa-1, which was expected to recognize capa-1 and capa-2 and, to a lesser degree, peptides with similar COOH-terminals, e.g., capa-3, eclosion-triggering hormone (ETH), and PBAN, a second antiserum against PBAN (expected to recognize PBAN and capa-3 and probably to cross react with ETH's capa-1 and capa-2), and a third against a linking region of the prepropeptide that does not encode any biologically active neuropeptide. The antiserum to capa-1 and PBAN recognized several cells in the larval nervous system (Fig. 2) that appear identical to myomodulin peritracheal cells (19). The latter cells are likely to contain ETH and, not necessarily, the capa peptides. Cross-reactivity of the capa-1 antiserum with Drosophila ETH would not be surprising, inasmuch as the COOH termini of these two peptides have similar structures (Fig. 1C).


View larger version (36K):
[in this window]
[in a new window]
  		Fig. 2.   Immunocytochemical localization of the capa peptides. In i-iv, larval central nervous system was single labeled with antibodies to different deduced peptides of the capa gene. i: Antibody to capa-2. In addition to the putative capa-expressing cells, this antiserum labels other cells in the subesophageal ganglion and also the thoracic FMRF-amide cells (which also cross-react with a large number of different antibodies). ii and iii: Antibody against part of the precursor that has presumably no biological activity but must reflect levels of the prepropeptide. At different focal planes, cell bodies and presumed neurohemal organs, the retrocerebral complex for the 2 cell bodies in the subesophageal neuromere, and the abdominal median nerves for the 3 pairs of abdominal neuroendocrine cells are shown in different slides. iv: Antibody against PBAN, which shows immunoreactivity very similar to that of the capa-2 antibody. In v, vi, and vii, CAPA-containing cells were labeled with the precursor antibody (blue), the PBAN antibody (green), and the CAP2b antibody (red), respectively. Tissues were incubated first with PBAN antiserum, then with fluorescein-labeled F(ab) fragments, and subsequently with 6-((7-amino-4-methylcoumarin-3-acetyl)amino)hexanoic acid succinimidyl ester-labeled antiprecursor and rhodamine-labeled anti-capa-2. PBAN- and capa-2-immunoreactive cells are clearly the same, even though the capa-2 labeling is somewhat weaker, in part probably because the PBAN and capa-2 antibodies compete for the same epitopes. RC, retrocerebral complex; SEG, subesophageal ganglion; MAN's, median abdominal nerves; ANC's, abdominal neuroendocrine cells; TNC's, thoracic neuroendocrine cells; CN, cerebral neuron.

To localize the capa peptides more definitively, we raised an antiserum to part of the capa gene product with no structural similarity to the ETH or hugin precursors. The latter antibody recognizes a subset of the capa-1 immunoreactive cells and did not recognize the peritracheal cells. The most strongly immunoreactive cells in the nervous system recognized by the capa precursor antibody have the morphology of neuroendocrine cells and are divided into two different groups. The first group consists of usually three pairs of ventral neuroendocrine cells in the abdominal neuromeres. In the larva, these cells use the surface of three pairs of abdominal median nerves as their neurohemal release site, while in the adult, the dorsal surface of the thoracicoabdominal ganglion is used. The second group consists of a single pair of very large neuroendocrine cells in the labial neuromere. In larvae and adults, the axons of these cells project to the cerebral ganglion and leave the brain by means of the nervi corporis cardiaci to the retrocerebral complex (Fig. 2). We believe that only these cells produce the capa precursor and are, hence, the only cells capable of producing capa-1 and capa-2. Significantly, we did not see staining with any of the antisera in the midline mesodermal cells previously implicated in CAP function (35). Thus it seems that the capa gene and its products are genuinely new members of the family.

All members of the CAP2b family stimulate epithelial fluid transport. Fluid secretion by Drosophila tubules is stimulated by all members of the CAP2b family, albeit to different extents (Fig. 3). By inspection, capa-1 is the most potent stimulator of fluid secretion (Fig. 3B). By contrast, fluid secretion rates are stimulated to the same extent by capa-2 at 10-4-10-7 M, with a dramatically diminished response at 10-8 M; furthermore, compared with capa-1 and CAP2b, there is no discernible rise in fluid secretion rates at 10-9 M. CAP2b stimulates fluid secretion maximally at 10-4-10-5 M, with dose-dependent stimulated secretion rates at lower concentrations. Inasmuch as capa-1 and capa-2 are encoded by the same gene, it is possible that they are coreleased, and so there is the potential for synergistic interaction between them; however, this appears not to be the case (Fig. 3C). Mixed peptides produce a response intermediate between each peptide individually.


View larger version (36K):
[in this window]
[in a new window]
  		Fig. 3.   All members of the CAP2b family stimulate epithelial fluid transport. A: typical experiment, showing fluid secretion stimulated by CAP2b, (), capa-1 (black-lozenge ), or capa-2 () at 10-7 M. Appropriate peptide was added at 30 min (arrow), and secretion rates were measured. Values are means ± SE (n = 10-12 tubules). At this concentration, capa-1 is more effective in raising fluid secretion rates than capa-2 or CAP2b. B: dose-response plots for fluid secretion stimulated by CAP2b (solid bars), capa-1 (stippled bars), and capa-2 (open bars) obtained from experiments performed as described in A. To normalize data between different experiments, and so to aid comparison, results are expressed as percent increase on peptide stimulation of basal rates (maximal stimulated rate - mean basal rate/basal rate × 100%). Values are means ± SE (n = 10-12 tubules). C: capa-1 and capa-2 do not act synergistically. Tubules were stimulated at 30 min with 10-7 M capa-1 (, n = 6), 10-7 M capa-2 (, n = 7), or both peptides at 5 × 10-8 M (black-lozenge , n = 9). They were then further stimulated with 10-7 M Drosophila leukokinin at 60 min. D: ETH1 and ETH2 elicit only small increases in fluid secretion by Drosophila tubules. ETH1 (open bars) and ETH2 (stippled bars) at 10-5-10-8 M were used in fluid secretion assays. ETH peptides were added at 30 min, and secretion rates were measured. Solid bar, capa-1 (10-7 M) used as a positive control. Values are expressed as in B (n = 5-10).

There is a distant structural similarity between the CAP2b-like peptides and ETH (Fig. 1C). ETH is known to act through NO, and so it was conceivable that the NO-stimulating properties of CAP2b merely reflected a cross-reaction with an ETH receptor. Accordingly, we synthesized ETH and found that it stimulated fluid secretion, but far less effectively than CAP2b (Fig. 3D); additionally, these peptides do not increase [Ca2+]i in principal cells. Therefore, the COOH-terminal PRx-amide motif common to the ETH and CAP2b families is not solely responsible for the physiological effects of CAP2b. It thus seems clear that the diuretic effects of capa-1 and capa-2 cannot be ascribed to cross-reaction with an ETH receptor.

All members of the CAP2b family increase [Ca2+]i in principal cells. Previous work described the CAP2b-induced rise in [Ca2+]i in principal, but not stellate, cells of the main segment (28). Here we show that these new members of the CAP2b family also induce a [Ca2+]i rise in principal cells, with similar kinetics (Fig. 4).


View larger version (34K):
[in this window]
[in a new window]
  		Fig. 4.   Capa-1 and capa-2 increase intracellular Ca2+ concentration ([Ca2+]i) in principal cells. A: typical traces of [Ca2+]i increases in principal cells induced by 10-7 M CAP2b (i), capa-1 (ii), and capa-2 (iii). For measurements of [Ca2+]i, 20 c42-aeq tubules per sample were stimulated with peptide (filled arrow) after a mock injection of Schneider's medium (open arrow). Each data point corresponds to 0.1 s and is typical of 15-20 experiments. B: dose-response curves for rise in [Ca2+]i in principal cells (i) and stellate cells (ii) elicited by each peptide. To enable comparison between all experiments, [Ca2+]i values are expressed as percent increase in peptide-stimulated [Ca2+]i of mocks, i.e., peptide-stimulated peak (nM) - mock (nM)/mock (nM) × 100%. Solid bars, CAP2b; stippled bars, capa-1; open bars, capa-2. Values are means ± SE, (n = 5-12).

All concentrations (10-4-10-11 M) of capa-1, capa-2, and CAP2b cause a rise in [Ca2+]i in principal cells, with no significant differences in the magnitude of the responses induced by all three members of the CAP2b family at 10-6-10-11 M. Capa-2, however, is significantly less effective than capa-1 or CAP2b at 10-4 and 10-5 M. At 10-11 M, capa-2 does not cause an elevation of [Ca2+]i. Surprisingly, given the efficacy of capa-1 in fluid transport assays, there is no discernible difference between the rise in [Ca2+]i induced by capa-1 and that induced by CAP2b.

Stellate cell [Ca2+]i increases significantly after stimulation with all CAP2b-like peptides at 10-7 M, although only capa-1 elicits a large enough change to be likely to be physiologically significant. However, there is no significant effect at 10-8 M. Interestingly, a capa-1-induced rise in [Ca2+]i in stellate cells may account, in part, for the dramatic increase in fluid secretion rates induced by this peptide. This effect of a CAP2b-like peptide on stellate cells has not been documented previously.

All members of the CAP2b family elevate NO. CAP2b was previously shown to have a unique, nitridergic mode of action; that is, it acts through intracellular Ca2+ to stimulate the calmodulin-modulated dNOS to generate NO in the same cell type that responds to the signal (4). Given that capa-1 and capa-2 peptides appear to act similarly to CAP2b, it is clearly important to establish whether these peptides are also nitridergic in their action. This is indeed the case (Fig. 4); with the use of the Griess reaction, all three peptides increase nitrite generation by Malpighian tubules. Previously, the nitridergic of effect CAP2b had been demonstrated using the arginine-citrulline conversion assay (4); these independent assays give very similar values for CAP2b stimulation of endogenous NOS activity: 1.5-fold by Griess reaction vs. 1.44-fold by arginine-citrulline conversion assay.

If this rise in NO is physiologically relevant, then blockade of the NO signal with the guanylate cyclase inhibitor methylene blue should reduce the effects of capa-1 and capa-2 on fluid secretion, as has been reported for CAP2b (4). Figure 5B shows that methylene blue inhibits diuresis caused by all members of the CAP2b family. Methylene blue fails to suppress the Ca2+ signal induced by the CAP2b-like peptides (Fig. 5C), so its effect on the capa-signaling pathway is through inhibition of soluble guanylate cyclase, rather than the Ca2+ signal. The fact that the Ca2+ signal is unaffected may also explain why methylene blue only partially inhibits the effect of CAP2b-like peptides on fluid secretion.


View larger version (45K):
[in this window]
[in a new window]
  		Fig. 5.   All members of the CAP2b family act through nitric oxide (NO) to raise cGMP. A: CAP2b-like peptides generate NO. Tubules were exposed to neuropeptides at 10-7 M, and nitrite generation was measured by the Griess reaction. * Significantly different from control. B: methylene blue attenuates CAP2b stimulation of fluid secretion rates. Fluid secretion stimulated by CAP2b, capa-1, and capa-2 was measured as previously described using 10-7 M peptide in the absence (open bars) or presence (solid bars) of 1 µM methylene blue. Methylene blue was added at time 0; CAP2b was added at 30 min. Methylene blue pretreatment does not alter basal rates of secretion (4). Data for CAP2b are from Ref. 4; data are expressed as in Fig. 3B (n = 10-12). * Significantly different from control (absence of methylene blue). C: methylene blue does not attenuate the CAP2b-like peptide-induced rise in [Ca2+]i. For measurements of [Ca2+]i, 20 c42-aeq tubules per sample were pretreated with 1 µM methylene blue for 10 min and then stimulated with each peptide at 10-7 M after a mock injection of Schneider's medium. To enable comparison among all experiments, [Ca2+]i values are expressed as percent increase of CAP2b-stimulated [Ca2+]i of mocks, i.e., CAP2b-stimulated peak (nM) - mock (nM)/mock (nM) × 100%. Open bars, control tubules; solid bars, methylene-blue treated tubules. Values are means ± SE (n = 5-12). Methylene blue does not significantly inhibit the rise in [Ca2+]i stimulated by any member of the CAP2b family. D: all members of the CAP2b family elevate intracellular cGMP levels. Intracellular cGMP levels in zaprinast-treated tubules (20 tubules per sample) were measured under control and CAP2b-stimulated conditions by RIA. Values are means ± SE (n = 4-6 repeats). E-G: confocal micrographs of tubules labeled with antibodies to cGMP show that capa-1 and capa-2 elevate cGMP only in principal cells. E: control; F: after stimulation with capa-1; G: after stimulation with capa-2. Images are representative of main segment cells and are equivalent sections one-third from the top focal plane of the tubule, taken at identical gain settings. Stellate cells do not label (arrows).

Application of CAP2b, capa-1, or capa-2 at 10-7 M results in an elevation of intracellular cGMP levels (Fig. 5D), as has been previously demonstrated for CAP2b (3). All three peptides elevate intracellular cGMP levels significantly above basal; however, capa-1-stimulated cGMP levels (15 ± 2.67 fmol/20 tubules) are significantly lower than capa-2- or CAP2b-stimulated cGMP levels (20 ± 1.2 and 26 ± 3.8 fmol/20 tubules, respectively). This suggests that, as discussed above, the cGMP signal may contribute only in part to the high rates of fluid secretion induced by capa-1. As shown in Fig. 5, E-G, the rise in intracellular cGMP is confined to the principal cells: stellate cells do not show detectable cGMP by immunocytochemistry. This is consistent with the results that the main [Ca2+]i increase is in principal cells and that only principal cells contain NOS.

Conclusion. The CAP2b peptide family is unusual in its function. The cardinal CAP2b acts through intracellular Ca2+ to stimulate an endogenous NOS, which acts in autocrine fashion through cGMP to stimulate a plasma membrane V-ATPase and, thus, accelerate fluid secretion. This mode of action is unique. Here, we report the first sequence for a gene encoding members of the CAP2b family and show that Drosophila contains two peptides, rather than one. We have shown here that the two novel peptides act on Drosophila tubules almost indistinguishably from M. sexta CAP2b. All three peptides act on the principal cell, and the responses to capa-1 and capa-2 are not additive, implying that multiple peptides, derived from different cells, can converge on a single signaling pathway in a single cell type and thus, quite possibly, but not necessarily, on a single receptor in that cell type.

Do the CAP2b-like peptides act on more than one cell type in Malpighian tubules? Inasmuch as CAP2b-like peptides act through NOS, it is quite conceivable that NO could diffuse to the stellate cells and exert an action there or that the stellate cells have receptors for capa peptides. We were unable to detect increases in stellate cell intracellular cGMP for any of the CAP2b-like peptides (Fig. 5), so any signal in stellate cells is unlikely to be mediated by NO. The targeted aequorin technology allows the resolution of [Ca2+]i signals in the principal and stellate cells. The cardinal CAP2b peptide produces no Ca2+ signals in stellate cells (Fig. 4) (28). However, capa-1 and capa-2 significantly increase stellate cell Ca2+ when applied at high concentration (Fig. 4B). A rise in stellate [Ca2+]i is necessary for activation of the chloride shunt conductance, although only the capa-1-induced signal is large enough to be likely to modulate cell function. Any activation of the chloride shunt conductance controlled by the stellate cells would act to collapse transepithelial potential difference, as is seen for leukokinin (20, 21). Interestingly, although physiological concentrations of CAP2b increase transepithelial potential difference, very high concentrations (10-5 M) have been shown to collapse it (3). It seems, therefore, that capa-1 and capa-2 may act on both cell types, and this parallel activation of cation transport and the chloride shunt pathway may explain its potency in stimulating fluid production, particularly at high concentrations (Fig. 3B). These results are consistent with a model in which CAP2b-like peptides act on G protein-coupled receptors to raise [Ca2+]i in both cell types, although the stellate cell receptor has lower affinity and is capa-1 selective. In principal cells, the [Ca2+]i signal is transduced through the Ca2+/calmodulin-sensitive dNOS (4, 28), whereas in stellate cells, which lack NOS (2), it acts on chloride channels (20, 21). The effect is to produce a broad response to CAP2b-like peptides over a wide concentration range (Fig. 5B). It is not clear, however, whether the concentrations of capa-1 and capa-2 required to stimulate the stellate cell would ever occur physiologically.

When producing antisera to the capa peptides, we anticipated cross-reactivity with Drosophila peptides having similar COOH termini; hence, we were not surprised that the capa-1 and PBAN antibodies recognized the same cell. However, unambiguous localization of the capa precursor was obtained using the third antiserum specific for this protein. The capa precursor is expressed in two different neuroendocrine cell types: a single pair in the labial neuromere and three pairs in the abdominal neuromeres of the ventral ganglion. It is possible that not all these cells will make capa-1, capa-2, and capa-3, inasmuch as the proteolytic cleavage sites in the precursor are not the same for the three peptides. Significantly, although capa-3 is flanked by dibasic cleavage sites, capa-1 and capa-2 have upstream dibasic cleavage sites but monobasic downstream signals. Expression of different convertases in the two cell types might be responsible for capa-1 and capa-2 being produced in only one of the two cell types expressing the capa precursor. Nevertheless, the neurohemal release sites of the neuroendocrine cells in the abdominal neuromeres are very close to the tissue previously found to contain CAP2b-like biological activity (35); hence, it seems almost certain that these abdominal neuroendocrine cells do indeed produce capa-1 and capa-2.

Why do CAP2b and its related peptides have such a unique mode of action? CAP2b was originally described in the context of a group of cardioactive peptides, and we speculate that CAP2b may contribute to a response orchestrated by the CAPs. NOS has been reported to be induced by parasitic infestation of mosquito Malpighian tubules (5), and taking these lines of argument together, we suggest (7) that CAP2b may act on tubules to modulate tubule NO response and, possibly, to flush the tubules of potentially harmful solutes or microorganisms. Inasmuch as osmoregulation is a critical function in an insect, it is plausible that inputs from multiple hormones will be integrated by the tubules, allowing them to respond appropriately to the needs of the insect. A second modulatory role for capa has recently emerged from a comprehensive survey of clock-regulated genes in Drosophila. Genome-wide microarray analysis has shown that the capa gene is regulated by clock (17), one of the key genes in circadian rhythmicity in Drosophila (10). Tubules are known to contain their own autonomous clock machinery (9) that can be reset by light (12). Capa peptides might thus modulate the tubule clock or tubule function. As we have outlined, the Drosophila Malpighian tubule is an ideal tissue for the detailed analysis of clock function, because physiological understanding is more detailed than for almost any Drosophila phenotype (7). This characterization of a gene encoding circadian-regulated neuropeptide may thus prove important in furthering our understanding of peripheral clocks and their function. Inasmuch as peptides closely similar to CAP2b have now been reported in Lepidoptera, Diptera, and molluscs, this peptide family may play an important role across a wide phylogenetic range of animals.


    ACKNOWLEDGEMENTS

This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC) to J. A. T. Dow and S. A. Davies, a BBSRC David Phillips Fellowship to S. A. Davies, and institutional funds to J. A. Veenstra.


    FOOTNOTES

Address for reprint requests and other correspondence: J. A. T. Dow, Div. of Molecular Genetics, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G11 6NU, UK (E-mail: j.a.t.dow{at}bio.gla.ac.uk).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

First published January 17, 2002;10.1152/ajpregu.00584.2001

Received 24 September 2001; accepted in final form 11 December 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1.   Cheung, CC, Loi PK, Sylwester AW, Lee TD, and Tublitz NJ. Primary structure of a cardioactive neuropeptide from the tobacco hawkmoth, Manduca sexta. FEBS Lett 313: 165-168, 1992.

2.   Davies, SA. Nitric oxide signalling in insects. Insect Biochem Mol Biol 30: 1123-1138, 2000.

3.   Davies, SA, Huesmann GR, Maddrell SHP, O'Donnell MJ, Skaer NJV, Dow JAT, and Tublitz NJ. CAP2b, a cardioacceleratory peptide, is present in Drosophila and stimulates tubule fluid secretion via cGMP. Am J Physiol Regulatory Integrative Comp Physiol 269: R1321-R1326, 1995.

4.   Davies, SA, Stewart EJ, Huesmann GR, Skaer NJV, Maddrell SHP, Tublitz NJ, and Dow JAT Neuropeptide stimulation of the nitric oxide signaling pathway in Drosophila melanogaster Malpighian tubules. Am J Physiol Regulatory Integrative Comp Physiol 273: R823-R827, 1997.

5.   Dimopoulos, G, Seeley D, Wolf A, and Kafatos FC. Malaria infection of the mosquito Anopheles gambiae activates immune-responsive genes during critical transition stages of the parasite life cycle. EMBO J 17: 6115-6123, 1998.

6.   Dow, JAT The multifunctional Drosophila melanogaster V-ATPase is encoded by a multigene family. J Bioenerg Biomembr 31: 75-83, 1999.

7.   Dow, JAT, and Davies SA. The Drosophila melanogaster Malpighian tubule. Adv Insect Physiol 28: 1-83, 2001.

8.   Dow, JAT, Maddrell SHP, Görtz A, Skaer NV, Brogan S, and Kaiser K. The Malpighian tubules of Drosophila melanogaster: a novel phenotype for studies of fluid secretion and its control. J Exp Biol 197: 421-428, 1994.

9.   Giebultowicz, JM, and Hege DM. Circadian clock in Malpighian tubules. Nature 386: 664-664, 1997.

10.   Hall, JC. Molecular neurogenetics of biological rhythms. J Neurogenet 12: 115-181, 1998.

11.   Huesmann, GR, Chung CC, Loi PK, Lee TD, Swiderek K, and Tublitz NJ. Amino acid sequence of CAP2b, an insect cardio-acceleratory peptide from the tobacco hornworm Manduca sexta. FEBS Lett 371: 311-314, 1995.

12.   Ivanchenko, M, Stanewsky R, and Giebultowicz JM. Circadian photoreception in Drosophila: functions of cryptochrome in peripheral and central clocks. J Biol Rhythms 16: 205-215, 2001.

13.   Jimenez, CR, Li KW, Dreisewerd K, Spijker S, Kingston R, Bateman RH, Burlingame AL, Smit AB, van Minnen J, and Geraerts WB. Direct mass spectrometric peptide profiling and sequencing of single neurons reveals differential peptide patterns in a small neuronal network. Biochemistry 37: 2070-2076, 1998.

14.   Kozak, M. Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo. Nature 308: 241-246, 1984.

15.   Kozak, M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44: 283-292, 1986.

16.   Marco, MP, Fabrias G, and Camps F. Development of a highly sensitive ELISA for the determination of PBAN and its application to the analysis of hemolymph in Spodoptera littoralis. Arch Insect Biochem Physiol 30: 369-381, 1995.

17.   McDonald, MJ, and Rosbash M. Microarray analysis and organization of circadian gene expression in Drosophila. Cell 107: 567-578, 2001.

18.   Nielsen, H, Engelbrecht J, Brunak S, and von Heijne G. A neural network method for identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Int J Neural Syst 8: 581-599, 1997.

19.   O'Brien, MA, and Taghert PH. A peritracheal neuropeptide system in insects: release of myomodulin-like peptides at ecdysis. J Exp Biol 201: 193-209, 1998.

20.   O'Donnell, MJ, Dow JAT, Huesmann GR, Tublitz NJ, and Maddrell SHP Separate control of anion and cation transport in Malpighian tubules of Drosophila melanogaster. J Exp Biol 199: 1163-1175, 1996.

21.   O'Donnell, MJ, Rheault MR, Davies SA, Rosay P, Harvey BJ, Maddrell SHP, Kaiser K, and Dow JAT Hormonally controlled chloride movement across Drosophila tubules is via ion channels in stellate cells. Am J Physiol Regulatory Integrative Comp Physiol 274: R1039-R1049, 1998.

22.   Park, Y, Zitnan D, Gill SS, and Adams ME. Molecular cloning and biological activity of ecdysis-triggering hormones in Drosophila melanogaster. FEBS Lett 463: 133-138, 1999.

23.   Perry, SJ, Dobbins AC, Schofield MG, Piper MR, and Benjamin PR. Small cardioactive peptide gene: structure, expression and mass spectrometric analysis reveals a complex pattern of co-transmitters in a snail feeding neuron. Eur J Neurosci 11: 655-662, 1999.

24.   Predel, R, and Eckert M. Tagma-specific distribution of FXPRLamides in the nervous system of the American cockroach. J Comp Neurol 419: 352-363, 2000.

25.   Predel, R, Kellner R, Rapus J, and Gade G. Allatostatins from the retrocerebral complex and antennal pulsatile organ of the American cockroach: structural elucidation aided by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. Regul Pept 82: 81-89, 1999.

26.   Quandt, K, Frech K, Karas H, Wingender E, and Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23: 4878-4884, 1995.

27.   Regulski, M, and Tully T. Molecular and biochemical characterization of dNOS---a Drosophila Ca2+ calmodulin-dependent nitric-oxide synthase. Proc Natl Acad Sci USA 92: 9072-9076, 1995.

28.   Rosay, P, Davies SA, Yu Y, Sozen MA, Kaiser K, and Dow JAT Cell-type specific calcium signalling in a Drosophila epithelium. J Cell Sci 110: 1683-1692, 1997.

29.   Sato, Y, Oguchi M, Menjo N, Imai K, Saito H, Ikeda M, Isobe M, and Yamashita O. Precursor polyprotein for multiple neuropeptides secreted from the suboesophageal ganglion of the silkworm Bombyx mori: characterization of the cDNA encoding the diapause hormone precursor and identification of additional peptides. Proc Natl Acad Sci USA 90: 3251-3255, 1993.

30.   Sozen, HA, Armstrong JD, Yang MY, Kaiser K, and Dow JAT Functional domains are specified to single-cell resolution in a Drosophila epithelium. Proc Natl Acad Sci USA 94: 5207-5212, 1997.

31.   Stangier, J, Hilbich C, Beyreuther K, and Keller R. Unusual cardioactive peptide (CCAP) from pericardial organs of the shore crab Carcinus maenas. Proc Natl Acad Sci USA 84: 575-579, 1987.

32.   Tager, HS. Coupling of peptides to albumin with difluorodinitrobenzene. Anal Biochem 71: 367-375, 1976.

33.   Terhzaz, S, O'Connell FC, Pollock VP, Kean L, Davies SA, Veenstra JA, and Dow JAT Isolation and characterization of a leucokinin-like peptide of Drosophila melanogaster. J Exp Biol 202: 3667-3676, 1999.

34.   Tublitz, NJ, Allen AT, Cheung CC, Edwards KK, Kimble DP, Loi PK, and Sylwester AW. Insect cardioactive peptides---regulation of hindgut activity by cardioacceleratory peptide-2 (CAP2) during wandering behavior in Manduca sexta larvae. J Exp Biol 165: 241-264, 1992.

35.   Tublitz, NJ, Bate M, Davies SA, Dow JAT, and Maddrell SHP A neuronal function for the midline mesodermal cells in Drosophila. Soc Neurosci Abstr 20: 533, 1994.

36.   Tublitz, NJ, Cheung CC, Edwards KK, Sylwester AW, and Reynolds SE. Insect cardioactive peptides in Manduca sexta--a comparison of the biochemical and molecular characteristics of cardioactive peptides in larvae and adults. J Exp Biol 165: 265-272, 1992.

37.   Veenstra, JA. Mono- and dibasic proteolytic cleavage sites in insect neuroendocrine peptide precursors. Arch Insect Biochem Physiol 43: 49-63, 2000.

38.   Veenstra, JA, and Davis NT. Localization of corazonin in the nervous system of the cockroach Periplaneta americana. Cell Tissue Res 274: 57-64, 1993.

38a.   Veenstra, JA, Lau GW, Agricola HJ, and Petzel DH. Immunohistological localization of regulatory peptides in the midgut of the female mosquito Aedes aegypti. Histochem Cell Biol 104: 337-347, 1995.

39.   Xu, WH, Sato Y, Ikeda M, and Yamashita O. Molecular characterization of the gene encoding the precursor protein of diapause hormone and pheromone biosynthesis-activating neuropeptide (DH-PBAN) of the silkworm Bombyx mori and its distribution in some insects. Biochim Biophys Acta 1261: 83-89, 1995.

Am J Physiol Regul Integr Comp Physiol 282(5):R1297-R1307
0363-6119/02 $5.00 Copyright © 2002 the American Physiological Society


This article has been cited by other articles:


Home page
 Physiol. GenomicsHome page
T. D. Southall, S. Terhzaz, P. Cabrero, V. R. Chintapalli, J. M. Evans, J. A. T. Dow, and S.-A. Davies
Novel subcellular locations and functions for secretory pathway Ca2+/Mn2+-ATPases
Physiol Genomics, September 14, 2006; 26(1): 35 - 45.
[Abstract] [Full Text] [PDF]

Home page
 Brief Funct Genomic ProteomicHome page
F. Hauser, M. Williamson, G. Cazzamali, and C. J. P. Grimmelikhuijzen
Identifying neuropeptide and protein hormone receptors in Drosophila melanogaster by exploiting genomic data
Brief Funct Genomic Proteomic, February 1, 2006; 4(4): 321 - 330.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
M. R. MacPherson, V. P. Pollock, L. Kean, T. D. Southall, M. E. Giannakou, K. E. Broderick, J. A. T. Dow, R. C. Hardie, and S. A. Davies
Transient Receptor Potential-Like Channels Are Essential for Calcium Signaling and Fluid Transport in a Drosophila Epithelium
Genetics, March 1, 2005; 169(3): 1541 - 1552.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Isabel, J.-R. Martin, S. Chidami, J. A. Veenstra, and P. Rosay
AKH-producing neuroendocrine cell ablation decreases trehalose and induces behavioral changes in Drosophila
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R531 - R538.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
V. P. Pollock, J. McGettigan, P. Cabrero, I. M. Maudlin, J. A. T. Dow, and S.-A. Davies
Conservation of capa peptide-induced nitric oxide signalling in Diptera
J. Exp. Biol., November 1, 2004; 207(23): 4135 - 4145.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
E. C. Johnson, L. M. Bohn, and P. H. Taghert
Drosophila CG8422 encodes a functional diuretic hormone receptor
J. Exp. Biol., February 15, 2004; 207(5): 743 - 748.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
K. E. Broderick, M. R. MacPherson, M. Regulski, T. Tully, J. A. T. Dow, and S. A. Davies
Interactions between epithelial nitric oxide signaling and phosphodiesterase activity in Drosophila
Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1207 - C1218.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
J. A. T. DOW and S. A. DAVIES
Integrative Physiology and Functional Genomics of Epithelial Function in a Genetic Model Organism
Physiol Rev, July 1, 2003; 83(3): 687 - 729.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
V. P. Pollock, J. C. Radford, S. Pyne, G. Hasan, J. A. T. Dow, and S.-A. Davies
norpA and itpr mutants reveal roles for phospholipase C and inositol (1,4,5)- trisphosphate receptor in Drosophila melanogaster renal function
J. Exp. Biol., March 1, 2003; 206(5): 901 - 911.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
P. Cabrero, J. C. Radford, K. E. Broderick, L. Costes, J. A. Veenstra, E. P. Spana, S. A. Davies, and J. A. T. Dow
The Dh gene of Drosophila melanogaster encodes a diuretic peptide that acts through cyclic AMP
J. Exp. Biol., December 15, 2002; 205(24): 3799 - 3807.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/5/R1297    most recent
00584.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend